Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Pacemakers Pipeline Market Report Overview

A pacemaker is a device designed to regulate the beating of the heart by providing electrical impulses which are delivered by the electrodes contacting the heart muscle.
The pacemakers pipeline market research report covers comprehensive information about the pipeline products with their comparative analysis at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Segments ·       Dual-Chamber Pacemakers

·       Single-Chamber Pacemakers

·       Dual-Chamber Leadless Pacemakers

·       Single-Chamber Leadless Pacemakers

Key Territories ·       The US

·       Europe

·       China

·       Japan

·       New Zealand

Key Regulatory Paths ·       PMA

·       CE

·       NMPA

·       Shonin

·       TGA

Leading Companies ·       Aalborg University

·       Arizona State University

·       Biotronik SE & Co KG

·       Boston Scientific Corp

·       Boston TransTec LLC

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Pacemakers Pipeline Market Segments

The key segments in the pacemakers pipeline market are dual-chamber pacemakers, single-chamber pacemakers, dual-chamber leadless pacemakers, and single-chamber leadless pacemakers. As of October 2024, both dual-chamber pacemakers and single-chamber pacemakers accounted for the highest number of pipeline products.

Pacemakers Pipeline Market Analysis by Segments, 2024 (%)

Pacemakers Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segmental Insights into the Pacemakers Pipeline Market

Download a Free Report Sample

Pacemakers Pipeline Market Segmentation by Territories

The key territories in the pacemakers pipeline market are the US, Europe, China, Japan, and New Zealand, among others. As of October 2024, the US accounted for the highest number of pipeline products.

Pacemakers Pipeline Market Analysis by Territories, 2024 (%)

Pacemakers Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Pacemakers Pipeline Market

Download a Free Report Sample

Pacemakers Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the pacemakers pipeline products market are PMA, CE, NMPA, Shonin, and TGA, among others. As of October 2024, PMA was the most followed pathway for pipeline products in the pacemakers market.

Pacemakers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Pacemakers Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Pacemakers Pipeline Market

Download a Free Report Sample

Pacemakers Pipeline Market – Competitive Landscape

A few of the leading companies associated with the pacemaker pipeline market are:

  • Aalborg University
  • Arizona State University
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • Boston TransTec LLC

Aalborg University: Headquartered in Aalborg, Denmark, Aalborg University (AAU) is a Danish public university that offers educational and research programs. The university’s main activities involve providing education, conducting research, and fostering cooperation with external partners. It offers a range of academic programs across various disciplines such as humanities, social sciences, and technical sciences, among others. AAU’s educational services cater to a diverse group of domestic and international students seeking higher education and research opportunities.

Arizona State University: Headquartered in Tempe, Arizona, US, Arizona State University (ASU) is an educational and research university that provides entrepreneurship solutions. The university carries out academic services and initiative consulting and provides graduate and undergraduate degree programs as well. ASU offers programs in various fields such as architecture and construction, arts, and business, among others. The university operates through its campuses in Tempe and Phoenix, the US.

Pacemakers Pipeline Market Analysis by Companies, 2024

Pacemakers Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Pacemakers Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Pacemakers Pipeline Market Segments Outlook (2024)

  • Dual-Chamber Pacemakers
  • Single-Chamber Pacemakers
  • Dual-Chamber Leadless Pacemakers
  • Single-Chamber Leadless Pacemakers

 

Pacemakers Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Japan
  • New Zealand


Pacemakers Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • CE
  • NMPA
  • Shonin
  • TGA

Scope

This report provides:

  • An extensive coverage of the pacemakers under development.
  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of pacemakers and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of pacemakers under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Aalborg University
Arizona State University
Biotronik SE & Co KG
Boston Scientific Corp
Boston TransTec LLC
Cairdac
Duke University
Hadassah Medical Center
InnerPulse Inc (Inactive)
Kenergy Inc.
Krisara Engineering, LLC
Medtronic Plc
MicroPort CRM SA
MicroPort Scientific Corp
Northwestern University
NuVascular Technologies Inc
Perpetuum Ltd
Rice University
Suzhou Singular Medical Co Ltd
Tau Pnu Medical Co., Ltd.
Thayer School of Engineering at Dartmouth
U.S. Stem Cell Inc
University of Arizona
University of Bern
University of California Los Angeles
University of Michigan
University of Southern California

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Pacemakers Overview

3 Products under Development

3.1 Pacemakers – Pipeline Products by Stage of Development

3.2 Pacemakers – Pipeline Products by Segment

3.3 Pacemakers – Pipeline Products by Territory

3.4 Pacemakers – Pipeline Products by Regulatory Path

3.5 Pacemakers – Pipeline Products by Estimated Approval Date

3.6 Pacemakers – Ongoing Clinical Trials

4 Pacemakers – Pipeline Products under Development by Companies

4.1 Pacemakers Companies – Pipeline Products by Stage of Development

4.2 Pacemakers – Pipeline Products by Stage of Development

5 Pacemakers Companies and Product Overview

5.1 Aalborg University Company Overview

5.1.1 Aalborg University Pipeline Products & Ongoing Clinical Trials Overview

5.2 Arizona State University Company Overview

5.2.1 Arizona State University Pipeline Products & Ongoing Clinical Trials Overview

5.3 Biotronik SE & Co KG Company Overview

5.3.1 Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview

5.4 Boston Scientific Corp Company Overview

5.4.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.5 Boston TransTec LLC Company Overview

5.5.1 Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview

5.6 Cairdac Company Overview

5.6.1 Cairdac Pipeline Products & Ongoing Clinical Trials Overview

5.7 Duke University Company Overview

5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

5.8 Hadassah Medical Center Company Overview

5.8.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview

5.9 InnerPulse Inc (Inactive) Company Overview

5.9.1 InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.10 Kenergy Inc. Company Overview

5.10.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.11 Krisara Engineering, LLC Company Overview

5.11.1 Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.12 Medtronic Plc Company Overview

5.12.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

5.13 MicroPort CRM SA Company Overview

5.13.1 MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview

5.14 MicroPort Scientific Corp Company Overview

5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

5.15 Northwestern University Company Overview

5.15.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

5.16 NuVascular Technologies Inc Company Overview

5.16.1 NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.17 Perpetuum Ltd Company Overview

5.17.1 Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.18 Rice University Company Overview

5.18.1 Rice University Pipeline Products & Ongoing Clinical Trials Overview

5.19 Suzhou Singular Medical Co Ltd Company Overview

5.19.1 Suzhou Singular Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.20 Tau Pnu Medical Co., Ltd. Company Overview

5.20.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

5.21 Thayer School of Engineering at Dartmouth Company Overview

5.21.1 Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview

5.22 U.S. Stem Cell Inc Company Overview

5.22.1 U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 University of Arizona Company Overview

5.23.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

5.24 University of Bern Company Overview

5.24.1 University of Bern Pipeline Products & Ongoing Clinical Trials Overview

5.25 University of California Los Angeles Company Overview

5.25.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

5.26 University of Michigan Company Overview

5.26.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.27 University of Southern California Company Overview

5.27.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview

6 Pacemakers- Recent Developments

6.1 Oct 08, 2024: LivaNova Appoints Susan Podlogar as a New Director

6.2 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results

6.3 Sep 26, 2024: Integer Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024

6.4 Sep 25, 2024: LivaNova to Announce Third-Quarter 2024 Results

6.5 Sep 19, 2024: ENO 3T MRI-Compatible Pacemaker Completes First Clinical Implantations in China, Featuring Innovative AutoMRI Technology

6.6 Sep 16, 2024: Microport CRM Celebrates 60 Years of Innovation: the Legacy of Our First Implantation

6.7 Sep 09, 2024: Abbott rolls out AVEIR DR leadless pacemaker across UK

6.8 Sep 05, 2024: Elutia Announces First Patient Implant of Elupro, the World’s First Drug-Eluting Bioenvelope for Cardiac Pacemakers and Neurostimulators

6.9 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.10 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.11 Aug 21, 2024: MicroPort CRM Receives EU Medical Device Regulation (MDR) Approval for ALIZEA, BOREA and CELEA Pacemakers Featuring Left Bundle Branch Area Pacing (LBBAP)

6.12 Aug 15, 2024: Abbott’s AVEIR DR – World’s First Dual Chamber Leadless Pacemaker System – Now Available in Canada

6.13 Aug 02, 2024: Nihon Kohden Announces Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2025

6.14 Jul 16, 2024: CVRx to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call on July 29th, 2024

6.15 Jun 27, 2024: FAU Researchers Develop an Alternative to Pacemakers

6.16 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.17 May 20, 2024: Vanderbilt Researchers Receive $2 Million ARPA-H Contract to Improve Software Security in Medical Devices

6.18 Apr 16, 2024: CVRx to Report First Quarter 2024 Financial and Operating Results and Host Conference Call on April 30th, 2024

6.19 Apr 05, 2024: MarinHealth Medical Center Becomes First Hospital in Northern California to Successfully Implant AVEIR DR, the World’s First Dual Chamber Leadless Pacemaker System

6.20 Mar 25, 2024: MicroPort CRM Announces the First Implantation of ALIZEA Bluetooth Pacemaker System in the United States

6.21 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.22 Mar 04, 2024: LivaNova to Present at the Barclays Global Healthcare Conference

6.23 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company

6.24 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering

6.25 Feb 15, 2024: Stephen Agostini Named UCLA’s Vice Chancellor and Chief Financial Officer

6.26 Feb 07, 2024: MicroPort CRM Receives Approval for Its ENO Pacing System in China

6.27 Feb 02, 2024: St. Joseph’s Children’s Hospital First in Tampa Bay to Implant Leadless Pacemaker in Pediatric Heart Patient

6.28 Jan 16, 2024: Shenzhen Xianjian Xinkang Medical Electronics Receives 510(K) Clearance For Temporary Cardiac Pacemaker

6.29 Jan 05, 2024: Medtronic Receives CE Mark for Its Next Generation Micra Leadless Pacing Systems

6.30 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results

6.31 Dec 20, 2023: ResMed Notifies Customers About Updated Instructions and Labeling for Masks with Magnets Due to Potential Interference with Certain Medical Devices

6.32 Dec 13, 2023: Abbott scientists: Innovating for People: A 135-Year Legacy Continues

6.33 Nov 07, 2023: Providence St. Joseph Hospital Implants First Dual Chamber Leadless Pacemaker on West Coast

6.34 Nov 07, 2023: Hoag Among the First in the World to Successfully Implant AVEIR DR, Recently FDA Approved Dual Chamber Leadless Pacemaker System

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Pacemakers – Pipeline Products by Stage of Development

Pacemakers – Pipeline Products by Segment

Pacemakers – Pipeline Products by Territory

Pacemakers – Pipeline Products by Regulatory Path

Pacemakers – Pipeline Products by Estimated Approval Date

Pacemakers – Ongoing Clinical Trials

Pacemakers Companies – Pipeline Products by Stage of Development

Pacemakers – Pipeline Products by Stage of Development

Aalborg University Pipeline Products & Ongoing Clinical Trials Overview

Self Powered Pacemaker – Product Status

Self Powered Pacemaker – Product Description

Arizona State University Pipeline Products & Ongoing Clinical Trials Overview

Wireless Pacemaker System – Product Status

Wireless Pacemaker System – Product Description

Biotronik SE & Co KG Pipeline Products & Ongoing Clinical Trials Overview

Amvia Stellar – Product Status

Amvia Stellar – Product Description

Solvia Rise – Product Status

Solvia Rise – Product Description

Biotronik SE & Co KG – Ongoing Clinical Trials Overview

Solvia Rise – BIO|MASTER.Amvia: Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker Family

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

EMPOWER Leadless Pacer – Product Status

EMPOWER Leadless Pacer – Product Description

INGENIO 2 PG – MICS – Product Status

INGENIO 2 PG – MICS – Product Description

Temporary RV VVI Pacemaker – Product Status

Temporary RV VVI Pacemaker – Product Description

Boston TransTec LLC Pipeline Products & Ongoing Clinical Trials Overview

Raul Pacemaker – Product Status

Raul Pacemaker – Product Description

Cairdac Pipeline Products & Ongoing Clinical Trials Overview

Autonomous Leadless Pacing System – Product Status

Autonomous Leadless Pacing System – Product Description

Duke University Pipeline Products & Ongoing Clinical Trials Overview

Tissue-Engineered Autonomous Pacemaker – Product Status

Tissue-Engineered Autonomous Pacemaker – Product Description

Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Aortic Pacemaker – Product Status

Aortic Pacemaker – Product Description

InnerPulse Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

InnerPulse Pacemaker – Product Status

InnerPulse Pacemaker – Product Description

Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview

Unconditional MRI Compatible Implantable Pacemaker – Product Status

Unconditional MRI Compatible Implantable Pacemaker – Product Description

Krisara Engineering, LLC Pipeline Products & Ongoing Clinical Trials Overview

Wireless Pacemaker – Product Status

Wireless Pacemaker – Product Description

Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview

Brady Wireless – Product Status

Brady Wireless – Product Description

Heart Pacemaker – Product Status

Heart Pacemaker – Product Description

Micra AR – Product Status

Micra AR – Product Description

Micra DDD Pacemaker – Product Status

Micra DDD Pacemaker – Product Description

MicroPort CRM SA Pipeline Products & Ongoing Clinical Trials Overview

Leadless Pacemaker – Product Status

Leadless Pacemaker – Product Description

Reply MRI Pacemaker – Product Status

Reply MRI Pacemaker – Product Description

Space MRI Pacemaker – Product Status

Space MRI Pacemaker – Product Description

TPG – External Temporary Pacemaker – Product Status

TPG – External Temporary Pacemaker – Product Description

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

Falcon MRI Pacemaker – Product Status

Falcon MRI Pacemaker – Product Description

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview

Implantable Pacing Device – Product Status

Implantable Pacing Device – Product Description

NuVascular Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Biological Pacemaker – Product Status

Biological Pacemaker – Product Description

Perpetuum Ltd Pipeline Products & Ongoing Clinical Trials Overview

Implantable Self-Energising Pacemaker – Product Status

Implantable Self-Energising Pacemaker – Product Description

Rice University Pipeline Products & Ongoing Clinical Trials Overview

Battery-Less Pacemaker – Product Status

Battery-Less Pacemaker – Product Description

Suzhou Singular Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Dual Chamber Pacemaker – Product Status

Dual Chamber Pacemaker – Product Description

Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview

Thru-Septal Pacemaker Lead – Product Status

Thru-Septal Pacemaker Lead – Product Description

Thayer School of Engineering at Dartmouth Pipeline Products & Ongoing Clinical Trials Overview

Self-Charging Pacemaker – Product Status

Self-Charging Pacemaker – Product Description

U.S. Stem Cell Inc Pipeline Products & Ongoing Clinical Trials Overview

BioPace – Product Status

BioPace – Product Description

University of Arizona Pipeline Products & Ongoing Clinical Trials Overview

Pacemaker – Product Status

Pacemaker – Product Description

University of Bern Pipeline Products & Ongoing Clinical Trials Overview

Batteryless Cardiac Pacemaker – Product Status

Batteryless Cardiac Pacemaker – Product Description

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

Intravascular Wirelessly Powered Micro-Pacer – Product Status

Intravascular Wirelessly Powered Micro-Pacer – Product Description

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

Cardiac Energy Harvesting Pacemaker – Product Status

Cardiac Energy Harvesting Pacemaker – Product Description

University of Southern California Pipeline Products & Ongoing Clinical Trials Overview

Fetal Micro-Pacemaker – Product Status

Fetal Micro-Pacemaker – Product Description

Micropacemaker – Product Status

Micropacemaker – Product Description

Glossary

Figures

Pacemakers – Pipeline Products by Stage of Development

Pacemakers – Pipeline Products by Segment

Pacemakers – Pipeline Products by Territory

Pacemakers – Pipeline Products by Regulatory Path

Pacemakers – Pipeline Products by Estimated Approval Date

Pacemakers – Ongoing Clinical Trials

Frequently asked questions

Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Pacemakers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.